A paradigm shift for targeted cancer therapy We know that recycling benefits our planet.
A paradigm shift for targeted cancer therapy We know that recycling benefits our planet; and now new research shows that the cellular version could be useful for battling cancer. Scientists at Stanford University possess identified a molecule that uses this unpredicted pathway to selectively eliminate cancer cells. The research, published by Cell Press in the July 8th problem of the journal Cancers Cell, may drive treatment strategies for cancer in an brand-new direction entirely. Renal cell carcinoma , the most common form of kidney cancer, is nearly always caused by mutation of the von Hippel-Lindau tumor suppressor gene and often does not respond well to treatment. Related StoriesFDA grants accelerated authorization for Tagrisso to take care of individuals with advanced NSCLCStudy shows rare HER2 missense mutations usually do not spread breasts cancer on the ownCornell biomedical engineers develop 'super organic killer cells' to destroy cancers cells in lymph nodes Since RCCs have a poor prognosis and so are refractory to standard chemotherapies, there is a have to develop new therapies for kidney tumor, says senior author Dr.Related StoriesAddressing quality of life needs in prostate cancer: an interview with Professor Louis DenisSurgical startup seeks financing to build virtual truth training libraryReducing hospital readmissions through Transitional Treatment: an interview with Rani Khetarpal’Social media is rapidly becoming an integral way to obtain medical information to millions of customers seeking to improve their overall health and discover effective treatment options,’ says Stan Valencis. ‘We value the FDA’s invitation to present our suggestions and their collaborative approach in seeking the suggestions of leaders over the healthcare industry. While technology is changing and as such quickly, needs to be reacted to quickly, we should maintain a balanced strategy that encourages technology while also making sure the security of consumers from resources of misinformation available via the web.’ The key communications from Stan Valencis’ testimony at the FDA’s open public hearings carried out in Washington, DC on November 12th and 13th include: – – Developing Need for Social Media in Culture – – Adoption of Social Press Amongst Healthcare Marketing Organizations – – Biggest Obstacles to Adoption Are Transparency, Liability and Best Practices – – Establish Authenticity of Medical Quite happy with Launch of FDA Press Full Details: Acsys Interactive’s FDA Recommendations Browse the Company’s detailed news release or view Stan Valencis talk with the FDA as the government agency evaluates special characteristics of Blogging platforms 2.0 and additional emerging technologies that may require the agency to provide additional guidance to the industry on how the regulations should be applied.
AHF phone calls on Sen.S.